Concentration-controlled everolimus versus MMF in De Novo heart transplant patients:: Incidence of CMV infection at 12 months post-transplant in a randomized trial

被引：1
|
作者：
Dengler, T. [1 ]
Vigano, M. [2 ]
Magelli, C. [3 ]
Guillemain, R. [4 ]
Varnous, S. [5 ]
Gerosa, G. [6 ]
Poncelet, A. [7 ]
Vanhaecke, J. [8 ]
Li, Y. [9 ]
Gezahegen, Y. [9 ]
机构：
[1] Heidelberg Univ, Heidelberg, Germany
[2] Univ Pavia, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy
[3] Az Osp Bologna, Policlin S Orsola Malpighi, Bologna, Italy
[4] Europeen Georges Pompidou, Paris, France
[5] Hop La Pitie Salpetriere, Paris, France
[6] Univ Padua, Azienda Osped Padova, Padua, Italy
[7] Clin Univ St Luc, Brussels, Belgium
[8] Univ Hosp Gasthuisberg, Louvain, Belgium
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 02期
关键词：
D O I：
10.1016/j.healun.2007.11.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [31] Mycophenolic Acid 12-Hour Area Under the Curve in De Novo Liver Transplant Patients Given Mycophenolate Mofetil at Fixed Versus Concentration-Controlled Doses
    Kamar, Nassim
    Marquet, Pierre
    Gandia, Peggy
    Muscari, Fabrice
    Lavayssi, Laurence
    Esposito, Laure
    Guitard, Joelle
    Canivet, Cindy
    Peron, Jean Marie
    Alric, Laurent
    Suc, Bertrand
    Saint-Marcoux, Franck
    Rostaing, Lionel
    THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 451 - 456
  • [32] Post-Kidney Transplant Valacyclovir versus Valganciclovir for CMV Prophylaxis: A Randomized Controlled Trial.
    Verghese, P. S.
    Matas, A.
    Chinnakotla, S.
    Evans, M.
    Balfour, H., Jr.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 354 - 354
  • [33] Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.
    Shihab, F.
    Shaffer, D.
    Qazi, Y.
    Kaplan, B.
    Vincenti, F.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    Peddi, V.
    TRANSPLANTATION, 2014, 98 : 537 - 537
  • [34] Everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in de novo cardiac transplant recipients: 12-month results from a multicenter, Randomized trial
    Arizon, Jose
    Lehmkuhl, Hans
    Livi, Ugolino
    Vigano, Mario
    Branzi, Angelo
    Almenar, Luis
    Gerosa, Gino
    Musumeci, Francesco
    Vamous, Shaida
    Maccherini, Massimo
    Hexham, Mark
    Mange, Kevin C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 211 - 211
  • [35] Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial
    Rashidi, Mitra
    Esmaily, Sorosh
    Fiane, Arnt E.
    Gude, Einar
    Tonseth, Kim A.
    Ueland, Thor
    Gustafsson, Finn
    Eiskjaer, Hans
    Radegran, Goran
    Dellgren, Goran
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 210 : 80 - 84
  • [36] Everolimus with Reduced CsA vs MMF with Standard CsA Exposure in De Novo Heart Transplant Recipients: 12 Month Efficacy and Safety Analysis
    Eisen, H.
    Pauly, D.
    Starling, R.
    Lehmkuhl, H.
    Ross, H.
    Kfoury, A.
    Wang, S.
    Cantin, B.
    Van Bakel, A.
    Zuckermann, A.
    Lopez, P.
    Dong, G.
    Panis, C.
    Jiang, H.
    Cornu-Artis, C.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S25 - S26
  • [37] Effect of Everolimus on Left Ventricular Hypertrophy of De Novo Kidney Transplant Recipients: A 1 Year, Randomized, Controlled Trial
    Paoletti, Ernesto
    Marsano, Luigina
    Bellino, Diego
    Cassottana, Paolo
    Cannella, Giuseppe
    TRANSPLANTATION, 2012, 93 (05) : 503 - 508
  • [38] De Novo Heart Transplant Recipients at Increased Risk of Cardiac Allograft Vasculopathy: IVUS Analysis of Specific Subpopulations Treated with Everolimus Versus MMF
    Starling, R.
    Pauly, D.
    Wang, S.
    Cantin, B.
    Ross, H.
    Burton, J.
    Eisen, H. J.
    Keogh, A.
    Dong, G.
    Jiang, H.
    Cines, M.
    Lopez, P.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 132 - 132
  • [39] Cyclosporine dose reduction in maintenance heart transplant patients following conversion from MMF/azathioprine to everolimus: Results at 12 months.
    Ross, H.
    Burton, J.
    Pflugfelder, P.
    Haddad, H.
    Cantarovich, M.
    White, M.
    Ignaszewski, A.
    Howlett, J.
    Dorent, R.
    Sips, C.
    Vaillancourt, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 445 - 445
  • [40] ONE-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED OPEN TRIAL DESIGNED TO REDUCE THE INCIDENCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Esmeraldo, Ronaldo
    Mb Oliveira, Maria Luiza
    Pinheiro, Petrucia Ma
    Girao, Celi M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 2
12345